Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day

PURPOSE: To evaluate the safety and efficacy in intraocular pressure (IOP) reduction of increasing Cosopt dosage from twice to three times a day. METHODS: The study included patients with primary open-angle glaucoma or ocular hypertension. After a washout period, IOP was measured at baseline, after...

Descripción completa

Detalles Bibliográficos
Autores principales: Shemesh, Gabi, Moisseiev, Elad, Lazar, Moshe, Kurtz, Shimon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292411/
https://www.ncbi.nlm.nih.gov/pubmed/22393279
http://dx.doi.org/10.2147/OPTH.S30321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292411/
https://www.ncbi.nlm.nih.gov/pubmed/22393279
http://dx.doi.org/10.2147/OPTH.S30321

Ejemplares similares